Health


 Why Scholar Rock’s Workforce Expansion Is Drawing Attention Across Biotechnology

Why Scholar Rock’s Workforce Expansion Is Drawing Attention Across Biotechnology

June 14, 2026 10:10 PM PDT| By Anmol Khazanchi

Scholar Rock expands organizational capabilities through new employee equity awards as the company continues advancing therapies for neuromuscular diseases.

 Can S&P 500 Healthcare Giant Abbott Boost Growth With Libre Duo?

Can S&P 500 Healthcare Giant Abbott Boost Growth With Libre Duo?

June 14, 2026 01:01 PM PDT| By Anmol Khazanchi

Abbott Laboratories (NYSE:ABT) advances healthcare innovation through devices, diagnostics, and nutrition products, reinforcing its global presence and role in the S&P 500 Index .

 Is NYSE Composite Pressure Mounting as UHS Faces Regulatory Scrutiny?

Is NYSE Composite Pressure Mounting as UHS Faces Regulatory Scrutiny?

June 14, 2026 11:28 AM PDT| By Anmol Khazanchi

Universal Health Services (NYSE:UHS) operates across acute and behavioral care, with regulatory developments shaping operations within the NYSE Composite Index healthcare landscape.

 Why Is Veeva Systems Stock Trending Right Now

Why Is Veeva Systems Stock Trending Right Now

June 13, 2026 09:59 PM PDT| By Anmol Khazanchi

Veeva Systems remains closely watched as healthcare technology developments, software platform discussions, and digital transformation themes drive visibility.

 Why Is CVS Health Stock Trending Right Now

Why Is CVS Health Stock Trending Right Now

June 13, 2026 04:52 AM PDT| By Anmol Khazanchi

CVS Health remains widely followed as healthcare service expansion, technology initiatives, and institutional ownership developments support continued visibility.

 Is Amgen Still Reasonable After Its Strong Run?

Is Amgen Still Reasonable After Its Strong Run?

June 13, 2026 04:02 AM PDT| By Anmol Khazanchi

Amgen's valuation debate centres on Horizon integration, cash flow strength, biotech risks, and whether strong gains already reflect future business expectations.

 Pfizer Draws Fresh Focus As Growth Strategy Evolves

Pfizer Draws Fresh Focus As Growth Strategy Evolves

June 13, 2026 02:09 AM PDT| By Anmol Khazanchi

Pfizer continues navigating industry change through innovation, pipeline expansion, strategic integration, and portfolio diversification, while market participants assess how these initiatives may influence long-term business direction.

 Harmony’s Next Growth Phase Faces A Bigger Test

Harmony’s Next Growth Phase Faces A Bigger Test

June 13, 2026 01:20 AM PDT| By Anmol Khazanchi

New clinical findings and ongoing regulatory initiatives are helping shape Harmony Biosciences' efforts to expand beyond its core franchise and strengthen its broader neurology strategy.

 GE HealthCare Stock Draws Attention After A Sharp Pullback

GE HealthCare Stock Draws Attention After A Sharp Pullback

June 13, 2026 12:47 AM PDT| By Anmol Khazanchi

Medical equipment demand, valuation signals, imaging needs, and hospital technology spending keep this healthcare name in focus as markets reassess its longer-term business outlook.

 Evolent Health Leads Healthcare Technology Sector Focus

Evolent Health Leads Healthcare Technology Sector Focus

June 12, 2026 02:22 PM PDT| By Anmol Khazanchi

Evolent Health continues attracting attention as healthcare providers embrace digital transformation, value-based care initiatives, analytics platforms, and technology-driven solutions designed to improve operational efficiency and patient outcomes.

 Danaher Masimo Deal Strengthens S&P 500 Healthcare Growth Story

Danaher Masimo Deal Strengthens S&P 500 Healthcare Growth Story

June 12, 2026 02:18 PM PDT| By Anmol Khazanchi

Danaher’s Masimo acquisition expands its healthcare technology portfolio, adding patient monitoring and sensor capabilities while strengthening its diagnostics platform and connected care growth story.

 Johnson & Johnson Lens Rollout Lifts Dow Healthcare Focus

Johnson & Johnson Lens Rollout Lifts Dow Healthcare Focus

June 12, 2026 01:25 PM PDT| By Anmol Khazanchi

Johnson & Johnson’s TECNIS PureSee rollout strengthens its eye care portfolio, adding focus to cataract surgery innovation, surgeon adoption, medical technology growth, and broader healthcare market relevance.

 Pfizer Draws Fresh Attention As Pipeline Activity Accelerates

Pfizer Draws Fresh Attention As Pipeline Activity Accelerates

June 12, 2026 12:33 PM PDT| By Anmol Khazanchi

Pfizer’s latest share move reflects renewed focus on rare-disease progress, research activity, dividend appeal, and the broader challenge of sustaining growth amid patent pressure.

 Is Eli Lilly's Growth Story Still Gaining Strength?

Is Eli Lilly's Growth Story Still Gaining Strength?

June 12, 2026 12:28 PM PDT| By Anmol Khazanchi

Recent drug milestones have strengthened focus on Eli Lilly's pipeline, valuation outlook, and future growth opportunities across obesity, diabetes, and dermatology treatments.

 Adaptive Biotechnologies Momentum Lifts Nasdaq Healthcare Focus

Adaptive Biotechnologies Momentum Lifts Nasdaq Healthcare Focus

June 12, 2026 12:25 PM PDT| By Anmol Khazanchi

Adaptive Biotechnologies continues advancing immune system research through innovative sequencing technologies, supporting precision medicine, disease monitoring, and diagnostic development within the evolving biotechnology and healthcare landscape.

 Is Doximity Struggling After Revenue Miss?

Is Doximity Struggling After Revenue Miss?

June 12, 2026 09:53 AM PDT| By Anmol Khazanchi

Doximity reported softer quarterly results, expanded AI initiatives, and attracted legal attention while maintaining a significant healthcare technology presence within the Russell 1000 Index .

 Why Is Novo Nordisk Stock Trending Right Now

Why Is Novo Nordisk Stock Trending Right Now

June 12, 2026 12:25 AM PDT| By Vivek Singh

Novo Nordisk remains a widely followed healthcare company as valuation discussions, treatment development themes, and pharmaceutical activity shape ongoing attention.

 Regeneron Keeps Biotech Execution In Focus Amid Market Volatility

Regeneron Keeps Biotech Execution In Focus Amid Market Volatility

June 11, 2026 11:37 AM PDT| By Anmol Khazanchi

Biotechnology remains under scrutiny as market volatility increases focus on pipeline quality, product demand, margin discipline, cash flow, and company-specific execution across regulated healthcare markets.

 Edwards Lifesciences Stock Watched As Procedure Recovery Matters

Edwards Lifesciences Stock Watched As Procedure Recovery Matters

June 11, 2026 11:31 AM PDT| By Anmol Khazanchi

Procedure recovery, hospital utilization, product adoption, and operating discipline remain central as healthcare names face a more selective market backdrop.

 Cencora Drug Distribution Story Gains Healthcare Market Attention

Cencora Drug Distribution Story Gains Healthcare Market Attention

June 11, 2026 11:28 AM PDT| By Anmol Khazanchi

Specialty drug demand, healthcare distribution, working capital discipline, margin control, customer retention, and financial flexibility continue shaping Cencora’s role in the U.S. healthcare market.

Recent Articles






Investing Tips

Previous Next